Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Michel Dib"'
Autor:
Michel Dib
Publikováno v:
Revue Neurologique. 179:S183
Autor:
Michel Dib
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2008, Iss Issue 5, Pp 1061-1078 (2008)
Michel DibFédération du système nerveux central, Hôpital de la Salpêtrière, Assistance Publique- Hôpitaux de Paris, FranceAbstract: Advances in our understanding of the pathophysiology of migraine have resulted in important breakthroughs in tr
Externí odkaz:
https://doaj.org/article/df88c9ce8a6e4c328234d41658eb292f
Autor:
Michel Dib
Publikováno v:
Revue Neurologique. 177:S139-S140
La therapie genique a ete initialement concue comme une approche therapeutique destinee aux maladies monogeniques, delivrant aux cellules un gene « sain » capable de suppleer le gene « malade ». Aujourd’hui, les modalites et les indications se
Autor:
Michel Dib
Publikováno v:
Journal of Spine & Neurosurgery.
Neurodegenerative diseases pose specific challenges for drug development. These diseases typically have a slow and variable clinical course, an insidious onset, and symptom expression is only observed when a significant proportion of neurons are alre
Autor:
Michel Dib, Hossein Pakdaman, Yomi Ogun, Hovhannes Manvelyan, Anna Czlonkowska, Ivan Milanov, Aurelio Mendez, Anatoly Fedin, Dodik Tugasworo, Siwaporn Chankrachang, Ihsan Zahra
Publikováno v:
European Journal of Medicinal Plants. 5:117-126
Autor:
Michel Dib, Pierre-François Pradat
Publikováno v:
Molecular Diagnosis & Therapy. 13:115-125
The only specific marker of sporadic amyotrophic lateral sclerosis (ALS) is neuropathologic, namely the presence of inclusions staining positively for ubiquitin and TAR DNA-binding protein (TARDBP, also known as TDP-43) in degenerating motor neurons.
Autor:
I. Kolev, D. Lardillier-Noel, Sophie Pittion, A. Furby, Annie Verschueren, Michel Dib, Marie-Hélène Soriani, J. Gonzales, Véronique Danel-Brunaud, François Salachas, Fausto Viader, Lucette Lacomblez, Pascal Cintas, Maurice Giroud, Christophe Vial, J.-P. Camdessanché, William Camu, Alain Destée, M. C. Arne-Bes, Laurence Carluer, E. Rousso, Christine Tranchant, Jean Pouget, D. Maugin, Philippe Couratier, N. Le Forestier, Guillaume Nicolas, P.-F. Pradat, Nadia Vandenberghe, Nathalie Guy, Jean-Christophe Antoine, Pierre Clavelou, Marie-Céline Fleury, Claude Desnuelle, Gaëlle Bruneteau, Emmanuel Broussolle, P. Corcia, Vincent Meininger
Publikováno v:
Revue Neurologique. 165:207-210
Autor:
Michel Lejoyeux, Imane Kermadi, Alain Payen, Michel Weber, Hervé Allain, Stéphanie Garcia-Acosta, Jean-Daniel Favre, Claudine Gillet, Elisabeth Frija-Orvoen, Henri-Jean Aubin, Michel Dib
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 20:511-519
Objective Cyamemazine is an original phenothiazine derivative which showed similar efficacy and tolerability to lorazepam during ethanol withdrawal in mice. This study investigated cyamemazine for its efficacy and tolerability in alcohol-dependent pa
Autor:
Françoise D’alche-Biree, Michel Dib, Jean-Pierre Olié, Marie-France Poirier, Dominique Januel
Publikováno v:
Journal of Affective Disorders. 76:191-200
The therapeutic efficacy of adding lithium to an ongoing antidepressant in resistant depression is well known. However there is less data concerning the efficacy of giving lithium and antidepressant concurrently from the start of treatment.The primar
Publikováno v:
Therapies. 58:127-131
La biodisponibilite d'une nouvelle formulation d'acetate de chlormadinone (1 comprime de Luteran® dose a 10 mg) a ete comparee a celle d'une formulation de reference (2 comprimes de Luteran® dose a 5 mg) apres administration orale unique d'une dose